Document is current
Any future updates will be listed below
-
Authors
Gilbert, Stephen http://orcid.org/0000-0002-1997-1689
Harvey, Hugh
Melvin, Tom http://orcid.org/0000-0001-6370-4177
Vollebregt, Erik
Wicks, Paul
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (16KISA100K)
- License Information
-
More Information
Article History
First Online: 30 June 2023
Competing interests
: S.G. has or has had consulting relationships with Una Health GmbH, Lindus Health Ltd, Flo Health Ltd, Thymia Ltd and Ada Health GmbH; and holds share options in Ada Health GmbH. E.V. is a partner of Axon Lawyers. H.H. is owner and managing director of Hardian Ltd. T.M. is an unpaid advisory board member of Pumpinheart Ltd; was previously a senior medical officer in medical devices at the Health Products Regulatory Authority, Ireland; and was previously co-chair of the Clinical Investigation and Evaluation Working Group of the European Commission. P.W. is employed by Wicks Digital Health Ltd, which has received funding from Ada Health, AstraZeneca, Biogen, Bold Health, Camoni, Compass Pathways, Corevitas, EIT, Endava, Happify, HealthUnlocked, Inbeeo, Kheiron Medical, Lindus Health, MedRhythms, PatientsLikeMe, Sano Genetics, Self Care Catalysts, The Learning Corp, The Wellcome Trust, THREAD Research, United Genomics, VeraSci and Woebot. P.W. and spouse are shareholders of WDH Investments Ltd, which owns stock in BlueSkeye AI Ltd, Earswitch Ltd, Sano Genetics Ltd and Una Health GmbH.
